GlassScriptPhysician profile
Danielle Renee Hayes
NPI 1659611416
$869.20
in general payments reported to CMS, 2019-2025
24 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $383 · 2022: $171 · 2023: $134 · 2024: $76.07 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $155.29 | 2021-2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $109.00 | 2021-2024 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.40 | 2021-2025 | Jardiance |
| Medtronic, INC. | $73.80 | 2022-2025 | Interstim |
| Daiichi Sankyo INC. | $62.27 | 2021-2024 | Enhertu |
| Novartis Pharmaceuticals Corporation | $61.22 | 2021-2025 | |
| Lilly USA, LLC | $38.61 | 2021 | |
| Myriad Genetic Laboratories, INC. | $29.96 | 2022 | |
| Boston Scientific Corporation | $27.74 | 2021 | |
| Tersera Therapeutics LLC | $26.43 | 2021-2022 | |
| Abbvie INC. | $24.82 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.62 | 2025 | Hyqvia |
| Pacira Pharmaceuticals Incorporated | $17.74 | 2023 | Exparel |
| Caris Mpi, INC. | $14.60 | 2025 | Mi Cancer Seek |
| Janssen Pharmaceuticals, INC | $14.47 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $13.73 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $13.41 | 2024 | Libtayo |
| Merck Sharp & Dohme LLC | $13.10 | 2021 | |
| Iovance Biotherapeutics, INC. | $13.04 | 2025 | Amtagvi |
| Ipsen Biopharmaceuticals, INC | $12.81 | 2021 | |
| Acceleron Pharma, INC. | $11.95 | 2021 | |
| Blueprint Medicines Corporation | $11.68 | 2022 | |
| Janssen Biotech, INC. | $11.47 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Hayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.